GUB014295 is a subcutaneously administered long-acting amylin agonist that also stimulates calcitonin receptors, according to ...
Novo Holdings and TA Associates have agreed to make an investment into Biocomposites.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback